Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin

Developmental Cell

Volumn 6, Issue 5, 2004, Pages 673-684

  Iezzi, Simona ^a   Di Padova, Monica ^a   Serra, Carlo ^b   Caretti, Giuseppina ^a   Simone, Cristiano ^b,c   Maklan, Eric ^a   Minetti, Giulia ^b   Zhao, Po ^d   Hoffman, Eric P ^d   Puri, Pier Lorenzo ^b,c   Sartorelli, Vittorio ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b DULBECCO TELETHON INSTITUTE   (Italy)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLISTATIN; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 4; MYOSTATIN; NEUTRALIZING ANTIBODY; RNA; SOMATOMEDIN C; TRICHOSTATIN A;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CELL SIZE; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; HORMONE SYNTHESIS; MOUSE; MULTINUCLEAR CELL; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; MYOTUBE; NONHUMAN; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; ANTIBODIES; CELL DIFFERENTIATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FEMALE; FOLLISTATIN; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MEMBRANE FUSION; MICE; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; MYOD PROTEIN; NFATC TRANSCRIPTION FACTORS; NIH 3T3 CELLS; NUCLEAR PROTEINS; REGENERATION; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 2342627231     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1534-5807(04)00107-8     Document Type: Article

References (42)

1. Ahn S. Olive M. Aggarwal S. Krylov D. Ginty D.D. Vinson C. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos Mol. Cell. Biol. 18 1998 967-977
2. Amthor H. Christ B. Rashid-Doubell F. Kemp C.F. Lang E. Patel K. Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth Dev. Biol. 243 2002 115-127
3. Aramburu J. Yaffe M.B. Lopez-Rodriguez C. Cantley L.C. Hogan P.G. Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A Science 285 1999 2129-2133
4. Armand A.S. Della Gaspera B. Launay T. Charbonnier F. Gallien C.L. Chanoine C. Expression and neural control of follistatin versus myostatin genes during regeneration of mouse soleus Dev. Dyn. 227 2003 256-265
5. Bilezikjian L.M. Corrigan A.Z. Blount A.L. Chen Y. Vale W.W. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells Endocrinology 142 2001 1065-1072
6. Bilezikjian L.M. Leal A.M. Blount A.L. Corrigan A.Z. Turnbull A.V. Vale W.W. Rat anterior pituitary folliculostellate cells are targets of interleukin-1beta and a major source of intrapituitary follistatin Endocrinology 144 2003 732-740
7. Bogdanovich S. Krag T.O. Barton E.R. Morris L.D. Whittemore L.A. Ahima R.S. Khurana T.S. Functional improvement of dystrophic muscle by myostatin blockade Nature 420 2002 418-421
8. Charge S.B. Rudnicki M.A. Cellular and molecular regulation of muscle regeneration Physiol. Rev. 84 2004 209-238
9. Conboy I.M. Rando T.A. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis Dev. Cell 3 2002 397-409
10. Cornelison D.D. Wold B.J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells Dev. Biol. 191 1997 270-283
11. Cornelison D.D. Olwin B.B. Rudnicki M.A. Wold B.J. MyoD(-/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient Dev. Biol. 224 2000 122-137
12. Du K. Asahara H. Jhala U.S. Wagner B.L. Montminy M. Characterization of a CREB gain-of-function mutant with constitutive transcriptional activity in vivo Mol. Cell. Biol. 20 2000 4320-4327
13. Friday B.B. Horsley V. Pavlath G.K. Calcineurin activity is required for the initiation of skeletal muscle differentiation J. Cell Biol. 149 2000 657-666
14. Furling D. Coiffier L. Mouly V. Barbet J.P. St Guily J.L. Taneja K. Gourdon G. Junien C. Butler-Browne G.S. Defective satellite cells in congenital myotonic dystrophy Hum. Mol. Genet. 10 2001 2079-2087
15. Germann A. Dihlmann S. Hergenhahn M. Doeberitz M.K. Koesters R. Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin Int. J. Cancer 106 2003 187-197
16. Glass D.J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy Nat. Cell Biol. 5 2003 87-90
17. Green H. Meuth M. An established pre-adipose cell line and its differentiation in culture Cell 3 1974 127-133
18. Hall-Craggs E.C. Seyan H.S. Histochemical changes in innervated and denervated skeletal muscle fibers following treatment with bupivacaine (marcain) Exp. Neurol. 46 1975 345-354
19. Herzig S. Long F. Jhala U.S. Hedrick S. Quinn R. Bauer A. Rudolph D. Schutz G. Yoon C. Puigserver P. et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 Nature 413 2001 179-183
20. Hill J.J. Davies M.V. Pearson A.A. Wang J.H. Hewick R.M. Wolfman N.M. Qiu Y. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum J. Biol. Chem. 277 2002 40735-40741
21. Hill J.J. Qiu Y. Hewick R.M. Wolfman N.M. Regulation of myostatin in vivo by GASP-1: a novel protein with protease inhibitor and follistatin domains Mol. Endocrinol. 17 2003 1144-1154
22. Horsley V. Jansen K.M. Mills S.T. Pavlath G.K. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth Cell 113 2003 483-494
23. Iemura S. Yamamoto T.S. Takagi C. Uchiyama H. Natsume T. Shimasaki S. Sugino H. Ueno N. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo Proc. Natl. Acad. Sci. USA 95 1998 9337-9342
24. Iezzi S. Cossu G. Nervi C. Sartorelli V. Puri P.L. Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases Proc. Natl. Acad. Sci. USA 99 2002 7757-7762
25. Lee S.J. McPherron A.C. Regulation of myostatin activity and muscle growth Proc. Natl. Acad. Sci. USA 98 2001 9306-9311
26. Lyons G.E. Ontell M. Cox R. Sassoon D. Buckingham M. The expression of myosin genes in developing skeletal muscle in the mouse embryo J. Cell Biol. 111 1990 1465-1476
27. Marks P.A. Richon V.M. Breslow R. Rifkind R.A. Histone deacetylase inhibitors as new cancer drugs Curr. Opin. Oncol. 13 2001 477-483
28. Matzuk M.M. Lu N. Vogel H. Sellheyer K. Roop D.R. Bradley A. Multiple defects and perinatal death in mice deficient in follistatin Nature 374 1995 360-363
29. McPherron A.C. Lawler A.M. Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member Nature 387 1997 83-90
30. Michael L.F. Asahara H. Shulman A.I. Kraus W.L. Montminy M. The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism Mol. Cell. Biol. 20 2000 1596-1603
31. Musaro A. Rosenthal N. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I Mol. Cell. Biol. 19 1999 3115-3124
32. Rando T.A. Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy J. Cell Biol. 125 1994 1275-1287
33. Rommel C. Bodine S.C. Clarke B.A. Rossman R. Nunez L. Stitt T.N. Yancopoulos G.D. Glass D.J. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways Nat. Cell Biol. 3 2001 1009-1013
34. Sampaolesi M. Torrente Y. Innocenzi A. Tonlorenzi R. D'Antona G. Pellegrino M.A. Barresi R. Bresolin N. De Angelis M.G. Campbell K.P. et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts Science 301 2003 487-492
35. Sidis Y. Schneyer A.L. Sluss P.M. Johnson L.N. Keutmann H.T. Follistatin: essential role for the N-terminal domain in activin binding and neutralization J. Biol. Chem. 276 2001 17718-17726
36. Tapscott S. Thayer M. Weintraub H. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis Science 259 1993 1450-1453
37. Wagner K.R. McPherron A.C. Winik N. Lee S.J. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice Ann. Neurol. 52 2002 832-836
38. Wang D. Christensen K. Chawla K. Xiao G. Krebsbach P.H. Franceschi R.T. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential J. Bone Miner. Res. 14 1999 893-903
39. Wells J. Boyd K.E. Fry C.J. Bartley S.M. Farnham P.J. Target gene specificity of E2F and pocket protein family members in living cells Mol. Cell. Biol. 20 2000 5797-5807
40. Whalen R.G. Harris J.B. Butler-Browne G.S. Sesodia S. Expression of myosin isoforms during notexin-induced regeneration of rat soleus muscles Dev. Biol. 141 1990 24-40
41. Yuspa S.H. Kilkenny A.E. Steinert P.M. Roop D.R. Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro J. Cell Biol. 109 1989 1207-1217
42. Zhao P. Iezzi S. Carver E. Dressman D. Gridley T. Sartorelli V. Hoffman E.P. Slug is a novel downstream target of MyoD. Temporal profiling in muscle regeneration J. Biol. Chem. 277 2002 30091-30101